6/15/2020 4:33:12 PM
Guardion Health Sciences Appoints David Evans As Interim President And Interim CEO
4/1/2020 7:19:57 AM
Guardion Health Sciences Receives Initial Order For $875K From Astramune Sdn Bhd For Exclusive Immuno-Supportive Formula
3/6/2020 8:06:41 AM
Guardion Health Sciences Receives $3.5 Mln From Exercise Of Warrants
8/15/2019 8:49:29 AM
Guardion Health Sciences Reports Increase In Pricing Of Public Offering
4/11/2019 9:20:41 AM
WallachBeth Capital Closes IPO Of 1.25 Mln Shares At $4.00/shr Of Guardion Health Sciences